irinotecan,leucovorin,oxaliplatin,nab-paclitaxel,gemcitabine
Ipsen
[]
napoli 3. there's no head to head trial but is really interesting to put this two trials together, specially in countries where nal-iri is not available #ascogi23 
Medical Oncologist

Gastrointestinal Cancer Department 

Hospital Clínic de Barcelona